Abstract
New therapeutics are urgently needed to combat the immense disease burden of tuberculosis and related mycobacterial diseases worldwide. Natural products continue to provide leads for the development of novel drugs to treat the rapidly growing numbers of patients with multi- and extensively-drug resistant tuberculosis. This review presents natural products and synthesized analogues with anti-mycobacterial activity published between 2006 through 2009. Structure activity relationships, synthetic analogues and newly reported activities of known compounds reported during this period are also included.
Keywords: Natural products, tuberculosis, drug development, mycobacterium tuberculosis, drug resistant tuberculosis, structure activity relationship
Current Topics in Medicinal Chemistry
Title:Natural Products as Leads for Tuberculosis Drug Development
Volume: 12 Issue: 7
Author(s): Christine E. Salomon and Lori E. Schmidt
Affiliation:
Keywords: Natural products, tuberculosis, drug development, mycobacterium tuberculosis, drug resistant tuberculosis, structure activity relationship
Abstract: New therapeutics are urgently needed to combat the immense disease burden of tuberculosis and related mycobacterial diseases worldwide. Natural products continue to provide leads for the development of novel drugs to treat the rapidly growing numbers of patients with multi- and extensively-drug resistant tuberculosis. This review presents natural products and synthesized analogues with anti-mycobacterial activity published between 2006 through 2009. Structure activity relationships, synthetic analogues and newly reported activities of known compounds reported during this period are also included.
Export Options
About this article
Cite this article as:
E. Salomon Christine and E. Schmidt Lori, Natural Products as Leads for Tuberculosis Drug Development, Current Topics in Medicinal Chemistry 2012; 12(7) . https://dx.doi.org/10.2174/156802612799984526
DOI https://dx.doi.org/10.2174/156802612799984526 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Antimicrobial Activity of Phenolics and Glucosinolate Hydrolysis Products and their Synergy with Streptomycin against Pathogenic Bacteria
Medicinal Chemistry Meet Our Editorial Board Member:
Current Computer-Aided Drug Design Cheminformatics Based Machine Learning Approaches for Assessing Glycolytic Pathway Antagonists of Mycobacterium tuberculosis
Combinatorial Chemistry & High Throughput Screening New Targets and Inhibitors of Mycobacterial Sulfur Metabolism
Infectious Disorders - Drug Targets Ceric Ammonium Nitrate Catalysed Stereoselective Synthesis of β-Aminoketones Using 3-Aryl-4-Formylsydnones
Letters in Organic Chemistry Diastereoselective Synthesis of Dispiropseudoindoxyls and Preparation of 9-Oxopyrrolo[ 1,2-α]Indoles
Current Organic Synthesis Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Protein & Peptide Letters Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Current Drug Metabolism Linezolid Induced Adverse Drug Reactions - An Update
Current Drug Metabolism Phytochemistry, Antinociceptive and Anti-inflammatory Actvities of Methanolic Leaves Extract of Lannea schimperi (Hoschst. Ex Rich) ENG.
Recent Patents on Biotechnology Nontuberculous Mycobacterium Infections in Rheumatoid Arthritis Patients: The Serodiagnosis of Pulmonary Disease due to Mycobacterium avium Complex with an Enzyme Immunoassay Kit Detecting Glycopeptidolipid Core Antigen (Capilia MAC Antibody ELISA)<sup>®</sup>)
Current Rheumatology Reviews The Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Infectious Disorders - Drug Targets Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies subject Index To Volume 3
Current Drug Targets New and Old Hot Drug Targets in Tuberculosis
Current Medicinal Chemistry Tuberculosis Drug Targets
Current Drug Targets In silico Analysis of Several Signal Peptides for the Excretory Production of Reteplase in Escherichia coli
Current Proteomics Medicinal Chemistry Perspective of Fused Isoxazole Derivatives
Current Topics in Medicinal Chemistry Microwave Assisted Preparation of New Dicoumarinyl Pyrazoline Derivatives as Antimicrobials
Current Microwave Chemistry